Delving into the Latest Updates on Artificial Bear Bile Powder with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Nervous System Diseases

Active Indication-

Inactive Indication

Habit Spasms

Originator Organization-

Active Organization-

Inactive Organization

Zhongshan Anshi Biopharmaceutical Co., Ltd.

Institute of Materia Medica

License Organization-

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

以中国健康成年受试者为研究对象，进行人工熊胆粉临床人体耐受性研究，从安全的初始剂量开始，观察人体对该药的耐受性及其产生的不良反应，确定安全耐受的人用剂量，了解在此剂量下的不良反应，为人工熊胆粉的临床应用的安全性提供数据支持。

[Translation]

Using healthy Chinese adult subjects as research subjects, a clinical human tolerance study of artificial bear bile powder was conducted. Starting from a safe initial dose, the tolerance of the human body to the drug and the adverse reactions it produced were observed, the safe and tolerable human dose was determined, the adverse reactions at this dose were understood, and data support was provided for the safety of the clinical application of artificial bear bile powder.

Start Date24 Feb 2019

Sponsor / Collaborator

Institute of Materia Medica

[+1]

100 Clinical Results associated with Artificial Bear Bile Powder

Login to view more data

100 Translational Medicine associated with Artificial Bear Bile Powder

Login to view more data

100 Patents (Medical) associated with Artificial Bear Bile Powder

Login to view more data

100 Deals associated with Artificial Bear Bile Powder

Login to view more data